| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.7M | +2.6% | +4.0% |
| R&D Expense | $1.1M | -23.9% | +162.2% |
| SG&A Expense | $141K | +101.4% | +51.3% |
| Operating Income | -$23.1M | +20.0% | -126.4% |
| Interest Expense | $13.7M | — | — |
| Pre-tax Income | -$27.3M | +15.0% | -191.3% |
| Income Tax | $42K | +35.5% | +12.5% |
| Net Income | -$27.4M | +15.0% | -190.6% |
| EPS (Basic) | -$0.18 | +40.0% | +37.9% |
| EPS (Diluted) | -$0.18 | +40.0% | +37.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.9M | +38.3% | -43.1% |
| Accounts Receivable | $998K | -11.8% | -40.9% |
| Current Assets | $16.8M | -2.2% | -67.8% |
| Total Assets | $44.1M | -2.8% | -54.2% |
| Current Liabilities | $340.2M | +3.8% | +267.5% |
| Total Liabilities | $340.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.1M | — | — |
| Investing Cash Flow | $1.5M | — | — |
| Financing Cash Flow | $17.6M | — | — |
| +232.6% |
| Stockholders' Equity | -$296.1M | -4.9% | -4953.6% |